Enhanced thrombin generation in normal and hypertensive pregnancy

Area of Science:

• Obstetrics and Gynecology
• Hematology
• Cardiovascular Medicine

Background:

• Pregnancy involves significant physiological changes affecting coagulation.
• Preeclampsia is a serious condition associated with increased thrombotic risk.
• Understanding coagulation dynamics in pregnancy is crucial for maternal health.

Purpose of the Study:

• To investigate plasma levels of thrombin-antithrombin III complexes and key coagulation inhibitors in normal pregnancy, preeclampsia, and gestational hypertension.
• To compare these levels against nonpregnant controls.
• To identify markers of a prethrombotic state in pregnancy, especially in preeclampsia.

Main Methods:

• Plasma samples were collected from women with uncomplicated pregnancy, preeclampsia, gestational hypertension, and nonpregnant controls.
• Levels of thrombin-antithrombin III complexes were measured.
• Levels of coagulation inhibitors: antithrombin III, protein C, and protein S were quantified.

Main Results:

• Normal pregnancy showed a progressive increase in thrombin-antithrombin III levels and a decrease in protein S levels.
• Preeclampsia exhibited elevated thrombin-antithrombin III levels.
• In preeclampsia, antithrombin III and protein C levels were reduced, with protein S levels not decreasing further compared to normal pregnancy.

Conclusions:

• Elevated thrombin-antithrombin III complexes indicate a prethrombotic state in normal pregnancy.
• Preeclampsia is characterized by a more pronounced prethrombotic state with significant alterations in coagulation inhibitors.
• These findings underscore the importance of monitoring coagulation in pregnancy, particularly in preeclamptic cases.